The role of Spectral Domain Optical Coherence Tomography in monitoring uncontrolled hypertensive type 2 diabetic patients
- PMID: 27057251
- PMCID: PMC4813620
The role of Spectral Domain Optical Coherence Tomography in monitoring uncontrolled hypertensive type 2 diabetic patients
Abstract
Rationale: The pathogenesis of diabetic retinopathy is multifactorial, and a range of hyperglycemia-linked pathways has been implicated in the initiation and progression of this condition. All the cells in the retina are affected by the diabetic milieu, and in view of such disease and tissue complexity, it is unlikely that any single process is solely responsible for the retinal pathophysiology. Dyslipidemia is considered a trigger to rapid worsening of the condition and its treatment is becoming a part of normal diabetes treatment. Nevertheless, as establishing causal mechanisms and related conditions remain an important research goal, also the means to follow up the impact on the retina and other ocular tissues are as important.
Objective: this retrospective study shows the progression of diabetic macular edema (DME) in patients with dyslipidemia related to poor glycemic and blood control in subjects with existing DME by measuring the total macular volume (TMV) and thickness through the spectral domain optical coherence tomography (SD- OCT).
Methods and results: 30 uncontrolled cases of type 2 diabetes that were measured monthly by SD- OCT through a period of 3 months with correlation to the degree of dyslipidemia and hyperglycemia, were analyzed.
Conclusion: The role of OCT in monitoring the progression of DME in patients with uncontrolled type 2 diabetes is essential and the collaboration between the ophthalmologist and endocrinologist is essential to monitor the course of disease in uncontrolled patients.
Keywords: hypertensive; spectral domain optical coherence tomography; type 2 diabetic patients.
Similar articles
-
Correlation between ganglion cell layer thinning and poor visual function after resolution of diabetic macular edema.Invest Ophthalmol Vis Sci. 2015 Jan 8;56(2):978-82. doi: 10.1167/iovs.14-15503. Invest Ophthalmol Vis Sci. 2015. PMID: 25574055
-
Correlation between spectral domain optical coherence tomography findings and fluorescein angiography patterns in diabetic macular edema.Ophthalmology. 2009 Jun;116(6):1158-67. doi: 10.1016/j.ophtha.2008.12.063. Epub 2009 Apr 23. Ophthalmology. 2009. PMID: 19395034
-
Neurodegeneration in Type 2 Diabetes: Evidence From Spectral-Domain Optical Coherence Tomography.Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6333-8. doi: 10.1167/iovs.15-17334. Invest Ophthalmol Vis Sci. 2015. PMID: 26436886
-
Optical coherence tomography in the diagnosis and management of diabetic macular edema: time-domain versus spectral-domain.Ophthalmic Surg Lasers Imaging. 2011 Jul;42 Suppl:S41-55. doi: 10.3928/15428877-20110627-04. Ophthalmic Surg Lasers Imaging. 2011. PMID: 21790110 Review.
-
Emerging Issues for Optical Coherence Tomography.Dev Ophthalmol. 2017;60:28-37. doi: 10.1159/000459723. Epub 2017 Apr 20. Dev Ophthalmol. 2017. PMID: 28427062 Review.
Cited by
-
A quantitative evaluation of the effect of meals on macular thickness in diabetic patients with diabetic macular edema.Oman J Ophthalmol. 2023 Oct 18;16(3):509-515. doi: 10.4103/ojo.ojo_21_23. eCollection 2023 Sep-Dec. Oman J Ophthalmol. 2023. PMID: 38059094 Free PMC article.
-
Retinal changes in diabetic patients without diabetic retinopathy.Rom J Ophthalmol. 2017 Oct-Dec;61(4):249-255. Rom J Ophthalmol. 2017. PMID: 29516043 Free PMC article.
References
-
- Rathmann W, Giani G. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:2568–2569. - PubMed
-
- Lam DW, LeRoith D. The worldwide diabetes epidemic. Curr. Opin. Endocrinol. Diabetes Obes. 2012;19:93–96. - PubMed
-
- Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 1993;329:977–986. - PubMed
-
- UK Prospective Diabetes Study Group G. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet. 1998;352:854–865. - PubMed
-
- Yu Y, Lyons TJ. A lethal tetrad in diabetes: hyperglycemia, dyslipidemia, oxidative stress, and endothelial dysfunction. Am J Med Sci. 2005;330:227–232. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical